ANGELA WHITE: Open Payments
NPI 1447473483 · FLEMING ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 11 payments from 10 companies in 2025. Trend: 2023 $27 · 2024 $487 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $122 |
| Biogen, Inc. | 1 | $102 |
| Vanda Pharmaceuticals Inc. | 1 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Orexo US, Inc. | 1 | $29 |
| Noven Therapeutics, LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Indivior Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: VRAYLAR, ZURZUVAE, FANAPT, CAPLYTA, Zubsolv, Xelstrym, REXULTI, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
